CCR2 and TLR3: noninvasive macrophage-associated biomarkers of acute renal transplant rejection

CCR2 和 TLR3:急性肾移植排斥反应的非侵入性巨噬细胞相关生物标志物

阅读:2

Abstract

BACKGROUND: The study aims to investigate the role and significance of macrophage-related genes in peripheral blood during acute renal transplant rejection. METHODS: Based on the dataset GSE15296, differential genes (DEGs) were intersected with macrophage-associated genes (MAGs), which defined as macrophage-associated genes (DEMAGs). Subsequently, GO and KEGG enrichment analyses were performed on DEMAGs. The PPI protein interaction network and machine learning were applied to identify Hub genes, which were also validated by GSE46474, an external validation set. We constructed a rat model of acute rejection of kidney transplantation and sequenced the transcriptome of the serum, and using the sequencing results, we analyzed the expression levels of the Hub gene. Then, a correlation analysis was carried out based on the Hub genes and different immune cell infiltration levels. Finally, GRNdb, miRDB, and GeneCards databases were applied to study the transcription factors, miRNAs, and regulatory drugs of Hub genes, respectively. RESULTS: The results of the Cibersort analysis revealed that M2-type macrophages were expressed higher in the Normal group. In addition, the results of the correlation analysis suggested that the expressions of Hub genes were negatively correlated with M1-type macrophages and positively correlated with M2-type macrophages. CONCLUSION: A diagnostic model of the macrophage-associated acute renal transplant rejection in peripheral blood was constructed based on CCR2 and TLR3, which can accurately diagnose the biological alterations of acute kidney transplant rejection. Meanwhile, these two Hub genes may become potential therapeutic targets in acute rejection of kidney transplantation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。